{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:18Z","timestamp":1786991238132,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Sanofi-Aventis Poland"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jad.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T16:09:01Z","timestamp":1307549341000},"page":"e13-e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Bipolarity and inadequate response to antidepressant drugs: Clinical and psychopharmacological perspective"],"prefix":"10.1016","volume":"136","author":[{"given":"Janusz K.","family":"Rybakowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2011.05.005_bb0005","first-page":"68","article-title":"Criteria for the \u201csoft\u201d bipolar spectrum: treatment implications","volume":"23","author":"Akiskal","year":"1987","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2011.05.005_bb0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2008.12.016","article-title":"Efficacy, safety and tolerability of quetiapine augmentation in treatment-resistant depression: an open-label pilot study","volume":"117","author":"Anderson","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jad.2005.05.011","article-title":"The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients","volume":"88","author":"Angst","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jad.2005.12.049","article-title":"The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention","volume":"91","author":"Balazs","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000314308","article-title":"Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants","volume":"62","author":"Bauer","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2011.05.005_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pnpbp.2006.08.003","article-title":"Challenging the unipolar\u2013bipolar division: does mixed depression bridge the gap?","volume":"31","author":"Benazzi","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/NDT.S5819","article-title":"Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues","volume":"5","author":"Bobo","year":"2009","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2011.05.005_bb0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/ern.10.44","article-title":"Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression","volume":"10","author":"Bobo","year":"2010","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jad.2011.05.005_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-009-1583-7","article-title":"Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice","volume":"206","author":"Bourin","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2011.05.005_bb0050","first-page":"38","article-title":"Predictors of bipolar disorder risk among patients currently treated for major depression","volume":"8","author":"Calabrese","year":"2006","journal-title":"MedGenMed"},{"key":"10.1016\/j.jad.2011.05.005_bb0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-009-1611-7","article-title":"Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder","volume":"206","author":"Chemoloz","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2011.05.005_bb0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.08.012","article-title":"Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder","volume":"1118","author":"Choi","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2011.05.005_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3810\/pgm.2010.07.2174","article-title":"Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed","volume":"122","author":"Citrome","year":"2010","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.jad.2011.05.005_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jad.2010.06.036","article-title":"Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?","volume":"127","author":"Correa","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0006-3223(92)90041-W","article-title":"Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression","volume":"32","author":"De la Fuente","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1192\/bjp.138.3.252","article-title":"Lithium induces rapid relief of depression in tricyclic antidepressant nonresponders","volume":"138","author":"De Montigny","year":"1981","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0085","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jad.2010.03.001","article-title":"Risk factors of treatment resistance in major depression: association with bipolarity","volume":"126","author":"Dudek","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0090","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4088\/JCP.v68n0714","article-title":"Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study","volume":"68","author":"Dunner","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145710000015","article-title":"Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study","volume":"13","author":"El-Khalili","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2011.05.005_bb0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jad.2004.08.004","article-title":"Antidepressant-associated chronic irritable dysphoria (ACID) in bipolar disorder","volume":"84","author":"El-Mallakh","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jad.2008.03.025","article-title":"Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients","volume":"111","author":"El-Mallakh","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2010.01.004","article-title":"Reducing the Hipomania Checklist (HCL-32) to a 16-item version","volume":"124","author":"Forty","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1176\/appi.ajp.161.1.163","article-title":"Antidepressant treatment in bipolar versus unipolar depression","volume":"161","author":"Ghaemi","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0120","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1176\/appi.ajp.2007.05122032","article-title":"Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD","volume":"164","author":"Goldberg","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/appi.ajp.2008.08050746","article-title":"Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD","volume":"166","author":"Goldberg","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1192\/bjp.bp.105.009969","article-title":"Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK","volume":"188","author":"Green","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0140","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1017\/S1092852900010324","article-title":"Lamotrigine augmentation strategy for patients with treatment-resistant depression","volume":"10","author":"Guitierez","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2011.05.005_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0150","doi-asserted-by":"crossref","unstructured":"Hammonds, M.D., Shim, S.S. 2009. Effect of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL\/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus. 105, 113\u2013119.","DOI":"10.1111\/j.1742-7843.2009.00416.x"},{"key":"10.1016\/j.jad.2011.05.005_bb0155","series-title":"3rd International Congress on Brain and Behaviour, 28.11.-02.12.2007, Theassaloniki, Greece","first-page":"S211","article-title":"Rate and risk factors of hypomania in recurrent and treatment resistant depression","volume":"7, Suppl.1","author":"Hantouche","year":"2007"},{"key":"10.1016\/j.jad.2011.05.005_bb0160","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1192\/bjp.109.463.810","article-title":"The use of lithium salts in affective disorders","volume":"109","author":"Hartigan","year":"1963","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0165","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0028-3908(02)00217-4","article-title":"Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamete excitotoxicity","volume":"43","author":"Hashimoto","year":"2002","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.jad.2011.05.005_bb0170","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.pnpbp.2007.11.024","article-title":"Aripiprazole as an adjunctive treatment for refractory unipolar depression","volume":"32","author":"Hellerstein","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0175","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1176\/appi.ajp.157.11.1873","article-title":"Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire","volume":"157","author":"Hirschfeld","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jad.2006.04.020","article-title":"Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity","volume":"95","author":"Inoue","year":"2006","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jad.2011.05.005_bb0185","first-page":"187","article-title":"Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability","volume":"21","author":"Ivkovic","year":"2009","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.jad.2011.05.005_bb0235","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","article-title":"N-desalquylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity","volume":"33","author":"Jensen","year":"2008","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2011.05.005_bb0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpsychires.2008.05.003","article-title":"A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to treat unipolar, non-psychotic major depression","volume":"43","author":"Keitner","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2011.05.005_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4088\/JCP.v63n0210","article-title":"Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature","volume":"63","author":"Ketter","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jad.2009.12.003","article-title":"The utility of Mood Disorder Questionnaire for the detection of bipolar diathesis in treatment-resistant depression","volume":"124","author":"Kiejna","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0205","first-page":"442","article-title":"Action thymoregulatrice a long terme de Depamide dans la psychose maniaco-depressive","volume":"2","author":"Lambert","year":"1971","journal-title":"Ann. Med. Psychol."},{"key":"10.1016\/j.jad.2011.05.005_bb0210","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1017\/S1461145710001082","article-title":"Brain-derived neurotrophic factor signaling mediates antidepressant effects of lamotrigine","volume":"14","author":"Li","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2011.05.005_bb0215","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1399-5618.2009.00762.x","article-title":"Inhibition of specific adenylyl cyclase isophorms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect","volume":"11","author":"Mann","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0220","first-page":"79","article-title":"Int\u00e9r\u00eat de la carbamaz\u00e9pine en association avec un antid\u00e9presseur insuffisament efficace. A propos de quatre observations","volume":"20","author":"Navarre","year":"1994","journal-title":"L'Enc\u00e9phale"},{"key":"10.1016\/j.jad.2011.05.005_bb0225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jad.2009.06.026","article-title":"Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies","volume":"120","author":"Nelson","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0230","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/342288","article-title":"The brain-derived neurotropic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study","volume":"71","author":"Neves-Pereira","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jad.2011.05.005_bb0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jad.2007.08.003","article-title":"Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk","volume":"107","author":"O'Donovan","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0245","first-page":"283","article-title":"Anti-manic and prophylactic effect of carbamazepine (Tegretol) on manic-depressive psychosis","volume":"27","author":"Okuma","year":"1973","journal-title":"Folia Psychiatr. Neurol. Jpn."},{"key":"10.1016\/j.jad.2011.05.005_bb0250","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v68n0602","article-title":"Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis","volume":"68","author":"Papakostas","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2006.03.028","article-title":"Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats","volume":"402","author":"Park","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jad.2011.05.005_bb0260","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.euroneuro.2008.12.012","article-title":"Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells","volume":"19","author":"Park","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2011.05.005_bb0375","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S146114570700795X","article-title":"Two generations of mood stabilizers","volume":"10","author":"Rybakowski","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2011.05.005_bb0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0924-977X(92)90027-6","article-title":"Adding lithium to antidepressant therapy: factors related to therapeutic potentiation","volume":"2","author":"Rybakowski","year":"1992","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2011.05.005_bb0270","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1017\/S1461145710000404","article-title":"Excellent lithium responders have normal cognitive functions and plasma BDNF levels","volume":"13","author":"Rybakowski","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Suppl.1","key":"10.1016\/j.jad.2011.05.005_bb0275","first-page":"S232","article-title":"Lithium or lamotrigine augmentation in treatment-resistant depression","volume":"9","author":"Rybakowski","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2011.05.005_bb0280","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000026610","article-title":"Potentiation of antidepressants with lithium or carbamazepine in treatment-resistant depression","volume":"40","author":"Rybakowski","year":"1999","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2011.05.005_bb0285","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2004.01.005","article-title":"Bipolar mood disorders among Polish psychiatric outpatients treated for major depression","volume":"84","author":"Rybakowski","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0290","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000100004","article-title":"Types of depression more frequent in bipolar than in unipolar affective illness: results of the Polish DEP-BI study","volume":"40","author":"Rybakowski","year":"2007","journal-title":"Psychopathology"},{"key":"10.1016\/j.jad.2011.05.005_bb0295","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-009-0030-4","article-title":"Polish version of the Hypomania Checklist (HCL-32) scale: the results in treatment-resistant depression","volume":"260","author":"Rybakowski","year":"2010","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2011.05.005_bb0300","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression","volume":"356","author":"Sachs","year":"2007","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.jad.2011.05.005_bb0305","first-page":"187","article-title":"Efficacy and safety of antidepressant augmentation with lamotrigine in patients with treatment-resistant depression: a randomized, placebo-controlled, double-blind study Prim. Care Companion","volume":"10","author":"Santos","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0310","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2009.10.027","article-title":"Lithium modulates tryptophan hydroxylase 2 gene expression and serotonin release in primary cultures of serotonergic raphe neurons","volume":"1307","author":"Scheuch","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2011.05.005_bb0315","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/YIC.0b013e328014823d","article-title":"Lithium versus lamotrigine augmentation in treatment-resistant depression: a randomized, open-label study","volume":"22","author":"Schindler","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2011.05.005_bb0320","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2004.01.015","article-title":"A closer look at treatment resistant depression: is it due to a bipolar diathesis?","volume":"84","author":"Sharma","year":"2005","journal-title":"J.Affect. Disord"},{"key":"10.1016\/j.jad.2011.05.005_bb0325","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0091-3057(96)00169-4","article-title":"Antidepressant-like effects of brain-derived neurotrophic factor (BDNF)","volume":"56","author":"Siuciak","year":"1997","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.jad.2011.05.005_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2009.10.033","article-title":"Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis","volume":"122","author":"Smith","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0335","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/15622970701317265","article-title":"Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies","volume":"9","author":"Suppes","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0340","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2009.10.007","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression","volume":"121","author":"Suppes","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2011.05.005_bb0345","series-title":"Clinical Descriptions and Diagnostic Guidelines","author":"The ICD-10 Classification of Mental and Behavioural Disorders","year":"1992"},{"key":"10.1016\/j.jad.2011.05.005_bb0350","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/13651500701749867","article-title":"The bipolar diathesis of treatment-resistant major depressive disorder","volume":"12","author":"Woo","year":"2008","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jad.2011.05.005_bb0355","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.pnpbp.2007.03.001","article-title":"Effects of paroxetine or milnacipram on serum brain-derived neurotrophic factor in depressed patients","volume":"31","author":"Yoshimura","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2011.05.005_bb0360","first-page":"683","article-title":"Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addidtion to paroxetine treatment","volume":"3","author":"Yoshimura","year":"2007","journal-title":"Neurpsychiatr. Dis. Treatm."},{"issue":"Suppl. 3","key":"10.1016\/j.jad.2011.05.005_bb0365","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1016\/S0924-977X(10)70516-2","article-title":"Adding an atypical antipsychotic drug induced a rapid increase of plasma BDNF levels in refractory depression","volume":"20","author":"Yoshimura","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2011.05.005_bb0370","first-page":"108","article-title":"Is clozapine a mood stabilizer?","volume":"56","author":"Zarate","year":"1996","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032711002515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032711002515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:10:20Z","timestamp":1759021820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032711002515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":75,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0165032711002515"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2011.05.005","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bipolarity and inadequate response to antidepressant drugs: Clinical and psychopharmacological perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2011.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}